This is reported by the Russian Direct Investment Fund (RDIF).
The study included data from more than 128 thousand residents of Moscow, divided into groups vaccinated with Sputnik V, as well as those who had recovered from coronavirus and a control group without immunity to SARS-CoV-2.
"The data on deaths among the study participants that occurred from June 1 to August 31, 2021 were analyzed. The effectiveness against deaths was 96% when vaccinated with both components of Sputnik V, while among people under 50 years of age, the effectiveness reached 100%," the RDIF said.
On April 20, the head of Rospotrebnadzor, Anna Popova, said that four cases of the Arcturus subspecies of coronavirus had been confirmed in Russia.
A surge in the incidence of the Arcturus coronavirus subvariant in Russia is predicted by the end of May.
Honored Doctor of Russia, epidemiologist, academician of the Russian Academy of Sciences Gennady Onishchenko, in an interview with the NSN, commented on the situation with the spread of COVID-19.